TRVI 424B5: Secondary offering
Filed with the SEC on · accession 0001193125-26-159041
TRVI filed a 424B5 (prospectus (offering)) with the SEC on Apr 16, 2026. Trevi Therapeutics is offering $150 million of its common stock in an underwritten public offering. The stock moved +1.9% by the first close after the filing.
Summary of the filing
Trevi Therapeutics is offering $150 million of its common stock in an underwritten public offering. The offering includes a 30-day option for underwriters to purchase an additional $22.5 million of shares.
Key details
How TRVI stock reacted
Close before
$14.27
Apr 15, 2026
First close after
+1.89%
$14.54
5 trading days
+3.71%
$14.80
Since filing
+0.42%
$14.33
✦ Ask GOAX AI about this filing — what it means for TRVI, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TRVI?
Click hereFrequently asked questions
What did TRVI file with the SEC on Apr 16, 2026?
TRVI filed a 424B5 (Secondary offering). Trevi Therapeutics is offering $150 million of its common stock in an underwritten public offering. The offering includes a 30-day option for underwriters to purchase an additional $22.5 million of shares.
What does a secondary offering mean for TRVI stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did TRVI stock react to this filing?
TRVI closed at $14.27 before the filing and $14.54 on Apr 16, 2026 (+1.89%). Five trading days later: $14.80 (+3.71%).
Other TRVI SEC filings
Get alerts when TRVI files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days